Trials / Sponsors / CoA Therapeutics, Inc., a BridgeBio company
CoA Therapeutics, Inc., a BridgeBio company
Industry · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A First in Human, Dose Escalation Study to Evaluate the Safety and Tolerability of BBP-671 in Healthy Voluntee Healthy Volunteers, Propionic Acidemia, Methylmalonic Acidemia | Phase 1 | 2021-03-25 |